Cellular therapy for lower back pain

This patent application teaches the use of stem cells for treatment of lower back pain through the stimulation of endogenous biological repair processes. The patent covers several mechanisms, as well as useful cell types and compositions of matter. Back pain costs the U.S. economy over $50 billion annually and represents the second most common reason for visits to a doctor. It is estimated that 10% of 50-year-old discs and 60% of 70-year-old discs are severely degenerated.